| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 22.73M | — |
| Operating expense | — | — |
| Net income | -2.91M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, HBIO returned +54.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +12.7% |
| 1 year | +54.1% |
| 5 years | -90.9% |
| 10 years | -72.1% |
| All-time high | $107.66 (Aug 2001) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in HBIO would be worth today ›No. Harvard Bioscience, Inc. has not paid a dividend in the past 12 months.
Harvard Bioscience, Inc. stock trades on NASDAQ under the ticker symbol HBIO.
Harvard Bioscience, Inc. is part of the Healthcare sector.
Harvard Bioscience, Inc. has a market cap of 34.37M USD, based on the latest quote.
Harvard Bioscience, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
